StrategIQ Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

StrategIQ Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$681K	Buy	5,013 +422	+9%	+$51.5K	0.08%	182
2023 Q3	$561K	Buy	4,591 +60	+1%	+$7.63K	0.07%	196
2023 Q2	$575K	Sell	4,531 -80	-2%	-$10.4K	0.07%	197
2023 Q1	$596K	Sell	4,611 -5	-0.1%	-$655	0.07%	177
2022 Q4	$606K	Sell	4,616 -120	-3%	-$15.5K	0.07%	176
2022 Q3	$554K	Buy	4,736 +275	+6%	+$34.1K	0.07%	177
2022 Q2	$525K	Buy	4,461 +2,841	+175%	+$337K	0.06%	181
2022 Q1	$211K	Buy	1,620 +10	+0.6%	+$1.3K	0.02%	283
2021 Q4	$246K	Buy	1,610 +233	+17%	+$36.1K	0.02%	268
2021 Q3	$223K	Hold	1,377	–	–	0.04%	206
2021 Q2	$225K	Buy	1,377 +31	+2%	+$4.78K	0.04%	203
2021 Q1	$203K	Buy	+1,346	New	+$214K	0.04%	203

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

StrategIQ Financial Group's IBB Position: Q4 2023 in Review

StrategIQ Financial Group increased its iShares Biotechnology ETF (IBB) stake by 9.2% in Q4 2023, buying an estimated $51.5K and bringing the position to 5,013 shares worth $681K. The position accounts for 0.08% of the portfolio, ranked #182.

StrategIQ Financial Group first reported a position in IBB in Q1 2021 and has held it in 12 quarters since. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

StrategIQ Financial Group held 5,013 shares of iShares Biotechnology ETF worth $681K as of Q4 2023.
StrategIQ Financial Group bought 422 iShares Biotechnology ETF shares in Q4 2023, an estimated $51.5K.
iShares Biotechnology ETF made up 0.08% of StrategIQ Financial Group's portfolio in Q4 2023, its #182 holding.
StrategIQ Financial Group first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 12 quarters since.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.